cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Ideaya Biosciences Inc
8 own
3 watching
Current Price
$37.63
$-2.54
(-6.32%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
2,548.71M
52-Week High
52-Week High
47.73500
52-Week Low
52-Week Low
14.33000
Average Volume
Average Volume
0.4M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization2,548.71M
icon52-Week High47.73500
icon52-Week Low14.33000
iconAverage Volume0.4M
iconDividend Yield--
iconP/E Ratio--
What does the Ideaya Biosciences Inc do?
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company s lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinical trial for patients with solid tumors having methylthioadenosine phosphorylase deletions; and IDE196, a protein kinase C inhibitor that is in Phase I/II clinical trial for genetically defined cancers having GNAQ or GNA11 gene mutations. Its preclinical pipeline includes various synthetic lethality programs targeting PARG inhibitor in tumors for patients having tumors with a defined biomarker based on genetic mutations and/or molecular signatures; Pol Theta inhibitors in tumors with BRCA or other homologous recombination deficiency mutations; and WRN inhibitors in tumors with high microsatellite instability. The company has a research collaboration agreement with Cancer Research UK and the University of Manchester to develop small molecule inhibitors of Poly (ADP-ribose) glycohydrolase; and a clinical trial collaboration and supply agreement with Pfizer Inc. for Phase I/II study in metastatic uveal melanoma, skin melanoma, and other solid tumors, as well as a strategic partnership with GlaxoSmithKline plc. IDEAYA Biosciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
Read More
How much money does Ideaya Biosciences Inc make?
News & Events about Ideaya Biosciences Inc.
PR Newswire
9 months ago
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) PR Newswire SOUTH SAN...
PR Newswire
11 months ago
IDEAYA Announces Pricing of Public Offering IDEAYA Announces Pricing of Public Offering PR Newswire SOUTH SAN FRANCISCO, Calif., April 24, 2023 SOUTH SAN FRANCISCO, Calif., April 24, 2023 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq:IDYA) today announced the pricing of an underwritten public...
PR Newswire
12 months ago
IDEAYA Announces Positive Interim Phase 2 Data for Darovasertib and Crizotinib Combination and Successful FDA Type C Meeting on Registrational Trial Design for Accelerated Approval in First-Line Metastatic Uveal Melanoma IDEAYA Announces Positive Interim Phase 2 Data for Darovasertib and Crizotinib...
PR Newswire
1 year ago
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) PR Newswire SOUTH SAN FRANCISCO, Calif., March 31, 2023 SOUTH SAN FRANCISCO, Calif., March 31, 2023 /PRNewswire/ -- IDEAYA...
Frequently Asked Questions
Frequently Asked Questions
What is Ideaya Biosciences Inc share price today?
plus_minus_icon
Can Indians buy Ideaya Biosciences Inc shares?
plus_minus_icon
How can I buy Ideaya Biosciences Inc shares from India?
plus_minus_icon
Can Fractional shares of Ideaya Biosciences Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Ideaya Biosciences Inc stocks?
plus_minus_icon
What is today’s traded volume of Ideaya Biosciences Inc?
plus_minus_icon
What is today’s market capitalisation of Ideaya Biosciences Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Ideaya Biosciences Inc?
plus_minus_icon
What percentage is Ideaya Biosciences Inc down from its 52-Week High?
plus_minus_icon
What percentage is Ideaya Biosciences Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$37.63
$-2.54
(-6.32%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00